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Abstract
Objective: Obstetrician=gynecologists (Ob=Gyn) and nurse practitioners (NP) are essential providers of primary
and preventive care for their female patients. Therefore, colorectal cancer (CRC) screening should be part of their
routine preventive practices. The purpose of our study is to evaluate the CRC screening practices of these pro-
viders.
Methods: A self-administered survey was mailed to a national sample of 1130 Ob=Gyns and NPs to assess
providers’ demographics, current CRC screening practices, and familiarity with CRC guidelines.
Results: Three hundred thirty-six providers (29.7%) returned our survey (54% Ob=Gyns and 46% NPs). Three
fourths of providers routinely performed screening for CRC, compared with 95% for breast and cervical cancer.
Routine CRC screening was more common among Ob=Gyns (87.2%) than NPs (61.7%) ( p< 0.001). Slightly over
half of providers correctly identified the recommended age to begin CRC screening for the average-risk patient,
with no significant difference between provider types. Overall, Ob=Gyns scored higher than NPs on a series of
questions assessing CRC screening ( p< 0.03). Several provider factors were found to be significantly associated
with screening practices, including practicing >10 years ( p< 0.01), practicing in a multispecialty group (2.62
times more likely), and having an older patient population ( p< 0.001).
Conclusions: Ob=Gyns and NPs underuse CRC screening compared with breast and cervical cancer screening
and lack knowledge about appropriate use of CRC screening modalities. Opportunities to further educate
Ob=Gyns and NPs should be sought to improve compliance with current CRC screening guidelines.
Introduction
Colorectal cancer (CRC) is the third leading cause ofcancer and cancer-related deaths in women.1 In 2007,
there will be an estimated 74,630 new diagnoses of colorectal
cancer and 26,180 associated deaths in women.1 The current
recommended CRC screening tests for cancer prevention and
cancer detection based on the most recent U.S. multisociety
task force guidelines (American College of Gastroenterology,
American College of Gastrointestinal Endoscopy, American
College of Physicians=Society of Internal Medicine, and
American Cancer Society) include colonoscopy every 10
years; flexible sigmoidoscopy, CT colonography, or barium
enema every 5 years; yearly fecal occult blood test (FOBT) or
fecal immunohistochemical test; and stool DNA, interval
unknown.2 Despite these recommendations, CRC screening
compliance among patients remains low. Data from the Na-
tional Behavioral Risk Factor Surveillance System (BRFSS) in
2004 demonstrated only a 57% adherence rate for all CRC
screening modalities.3
Women are less likely than men to be up-to-date with their
CRC screening.4–11 Therefore, it is critical to examine the CRC
screening practices of physicians and nurse practitioners
(NPs) who routinely provide primary care to women. Studies
have shown that 38%–93% of gynecologists report providing
primary care to their patients.12–14 Since 1996, the Council on
Resident Education in Obstetrics and Gynecology has recog-
nized the importance of their discipline’s role in women’s
primary healthcare and has required 6 months of primary
care in their curriculum. In addition, NPs are use regularly in
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obstetrician=gynecologist (Ob=Gyn) practices and routinely
perform health maintenance examinations. Thus, it is critical
to ensure that CRC screening has been incorporated into both
the Ob=Gyns’ and NPs’ preventive screening practices.
The objective of this study is to examine current CRC
screening practices relative to nationally accepted guidelines
and other preventive screening practices, such as mammog-
raphy and cervical cancer screening, in a nationally repre-
sentative sample of Ob=Gyns and NPs.
Materials and Methods
Sample population
After attaining IRB approval at the University of Michigan,
we surveyed a nationally representative sample of Ob=Gyns
and NPs in 2005–2006. The American Medical Association’s
Physician Masterfile was used as the sampling frame. The
eligible population consisted of Ob=Gyns and NPs aged 75
years with an active license; 5526 individuals (1715 Ob=Gyns
and 3811 NPs) met these eligibility criteria. A cross-section of
the eligible population was selected using a systematic,
stratified random sampling approach, which yielded 565 in
each group of providers for a total of 1130 potential respon-
dents. No information was collected on nonrespondents.
Survey methods
A survey was mailed to all 1130 potential respondents. To
enhance participation, nonresponders were sent a reminder
postcard 1 month after the initial survey mailing. An addi-
tional mailing to nonresponders was conducted 12 weeks
after the initial survey mailing. The survey instrument was
composed of 31 questions and was based on constructs from
previously used surveys.15,16 Data regarding personal and
practice demographics were ascertained, including sex, race=
ethnicity, practice type, community size, years in practice,
percentage of primary care practice, percentage of patients
aged 50, and weekly patient volume. To assess baseline
general preventive patient practices, we inquired about use of
mammography, Papanicolaou (Pap) smear, and bone densi-
tometry testing.
CRC screening methods were evaluated by determining
the most frequent methods used; use of in-office vs. in-home
FOBT; FOBT testing restrictions, such as avoiding meat, an-
ticoagulants, and nonsteroidal anti-inflammatory drugs
(NSAIDs); and age to initiate CRC screening in patients of
various risk (i.e., with or without a family history of CRC or
adenomatous polyps). Finally, we asked participants to assess
CRC screening candidacy in three clinical scenarios that were
representative of varying patient risk levels for CRC: patients
with a history of ulcerative colitis, positive FOBT, or adeno-
matous polyp.
Statistical analysis
The primary outcome measure was the reported routine
use of CRC screening. A secondary outcome was the reported
routine use of a recommended method of CRC screening. We
compared the routine use of CRC screening with routine
breast and cervical cancer screening and bone densitometry
testing. We then examined demographic predictors of routine
use of CRC screening, including age, race=ethnicity, prac-
tice type, number of years in practice, proportion of visits
classified as primary care, and the proportion of patients 50
years.
Knowledge about CRC screening was measured by creating
a summary score from answers to six individual items. These
items addressed the age to start screening for an average-risk
patient, age to start screening in a patient with a first-degree
relative diagnosed with CRC or adenomatous polyp <60 and
>60 years old, and three hypothetical clinical scenarios. The
three clinical scenarios presented included a patient with a
positive FOBT, a patient with a history of ulcerative colitis that
affected the entire colon, and a patient with a personal his-
tory of an adenomatous polyp. Each correct answer was worth
1 point, and all other answers were worth 0 points. The total
score was calculated by summing the points generated by each
individual answer.
Each potential predictor variable was first examined in
relation to routine use of CRC screening; bivariate analyses
were performed using chi-square tests for categorical vari-
ables and Student’s t tests for continuous variables. Multi-
variable logistic regression analysis was subsequently
performed to determine the adjusted odds ratios (OR) of
variables that achieved bivariate statistical significance.
p values of <0.05 were considered statistically significant. All
statistical analyses were done using SPSS version 13.0 (SPSS,
Chicago, IL).








Female* 81 (44.5%) 150 (97.4%)
Age, years,*
mean (SD) 55.5 (8.3) 50.9 (8.4)
Race
Caucasian 150 (83.7%) 135 (88.8%)
Other 29 (16.2%) 17 (11.2%)
Practice type*
Private 147 (80.1%) 66 (42.9%)
Multispecialty 18 (9.9%) 11 (6.0%)
Academic 7 (3.8%) 20 (12.6%)
HMO 1 (0.5%) 8 (5.2%)
Community size*
<50,000 34 (18.9) 34 (22.3)
51,000–100,000 37 (20.1) 48 (31.6)
>100,000 109 (60.6) 70 (46.1)
Years practicing*
<5 8 (4.4) 13 (8.4)
5–10 4 (2.2) 34 (22.1)
>10 169 (92.9) 107 (69.5)
% of visits classified as
primary care, mean (SD)*
38.6% (33.7) 29.0% (32.4)
No. who provide primary
care
157 (86.3) 126 (81.8%)
Patients seen per week,
mean number (SD)*
70.0 (31.8) 60.7 (34.4)
% of patients 50 years,
mean (SD)*
42.5% (23.5) 20.7% (23.5)
*p< 0.05.
aNumbers may not equal 100% because of multiple or missing
answers by respondents.
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Results
Characteristics of study population
Of the 1130 potential respondents, 336 (29.7%) returned the
mailed survey. The study population comprised 182 (54%)
Ob=Gyns and 154 (46%) NPs. Characteristics of the study
population are described in Table 1. Overall, most respon-
dents were Caucasian (84.8%), worked in private practice
settings (63.4%), and had been in practice for >10 years
(82.1%). Compared with NPs, a greater proportion of the
Ob=Gyns were male, older, worked in private practice set-
tings, worked in larger communities, had been in practice for
>10 years, and cared for an older patient population.
Preventive screening practices
Routine screening practices of Ob=Gyns and NPs are
shown in Table 2. A significantly larger proportion of Ob=
Gyns (87.2%) reported ordering or performing CRC screening
compared with only 61.7% of NPs ( p< 0.01). However, CRC
screening was ordered less than mammography and cervical
cancer screening among both provider groups, but more fre-
quently than cholesterol and bone mineral density (BMD)
screening. Routine CRC screening was significantly associ-
ated with routine use of other preventive screening practices
( p< 0.001).
Practitioner personal preferences
Respondents were asked to indicate their preferences for
their own personal CRC screening; 67% preferred colono-
scopy. Sixty-three percent of Ob=Gyns and 24% of NPs had
themselves already undergone a colonoscopy or FOBT by the
time of the survey.
CRC screening method used and follow-up
of positive screening tests
Overall, the most common CRC screening methods used
for patients were FOBT and colonoscopy (76.2% and 28.3%,
respectively). A significantly larger proportion of Ob=Gyns
(37.0%) reported ordering colonoscopy compared with only
19.8% of NPs ( p< 0.005). Sixty-eight percent of providers
performed FOBT using in-office digital rectal examination;
30% reported using in-office digital rectal examination ex-
clusively as their CRC screening modality. Of the remaining
respondents, 15% of providers used in-home FOBT exclusively
and 36% used both in-home and in-office FOBT. If a patient’s
FOBT was positive, 61% of providers indicated they would
refer for colonoscopy, yet 21% would repeat the FOBT. Al-
though most providers reported screening routinely for CRC,
many were not correctly using the five recommended screen-
ing methods and did not respond to positive testing in ac-
cordance to current recommendations.
CRC screening knowledge
Table 3 shows providers’ performance on survey items
measuring knowledge. Overall, 55.4% of providers identified
the correct age (50 years) to initiate CRC screening in patients
of average risk; one third (33.2%) of respondents thought CRC
screening should be initiated at 40 years of age, and 8.2%
thought that it should be initiated at 45 years of age. Gen-
erally, Ob=Gyns performed better than NPs on most items.
Most providers in either group were unable to identify the
correct age to begin screening in patients with a first-degree
relative with CRC=polyps at age >60. Fifty-five percent of
providers thought that it was never appropriate to discontinue
Table 2. Screening Methods Reported
by Obstetrician=Gynecologists (Ob=Gyn)






Order CRC screening* 157 (87.2%) 95 (61.7%)
Mammography* 178 (98.9%) 140 (90.9%)
Cervical cancer screening* 176 (97.8%) 145 (94.8%)
Cholesterol 95 (52.8%) 64 (42.1%)
Order bone mineral
densitometry (DEXA)*
129 (71.7%) 72 (47.1%)
Correct screening method 109 (59.9%) 92 (59.7%)
*p< 0.01.





(correct answer) Ob=Gyn (%)
Nurse
practitioner (%)
Age to begin screening
for average risk
patient (age 50)
104 (57.1) 82 (53.2)
Age to begin screening

























176 (96.7) 137 (88.9)





76 (41.6) 65 (42.2)
Knowledge score,*
mean, SD
4.36 (1.11) 4.09 (1.32)*
*p< 0.05.
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CRC screening regardless of age. There was a significant
correlation between knowledge and routine CRC screening
(correlation coefficient¼ 0.289, p< 0.01) but not between
knowledge and screening using a recommended method.
Even after adjusting for provider type, years in practice, and
practice type, this relationship remained statistically signifi-
cant ( p< 0.001).
Provider factors associated with CRC screening
Several provider and practice factors were significantly
associated with routine CRC screening in bivariate analyses,
including provider type, provider sex, multispecialty prac-
tice type, greater number of years in practice, greater pro-
portion of patient 50, higher mean number of visits per
week, and high proportion of visits characterized as pri-
mary care ( p< 0.02 for each variable). After adjusting for
factors achieving bivariate significance, providers in multi-
specialty groups were 2.62 times more likely to report routine
CRC screening compared with those in single specialty pri-
vate practices (95% confidence interval [CI] 1.21-5.68). The
adjusted OR of routine screening for a 1 percentage point
increase in the proportion of patients >50 years old was 0.981
(95% CI 0.967-0.996), which corresponds to an approximately
17% decrease in the likelihood of routine screening for every
10 percentage point increase in the proportion of patients >50
years old. Those in practice between 5 and 10 years were 2.56
times more likely to report routine screening than those in
practice >10 years (95% CI 1.1-5.97). Provider gender was not
associated with routine screening, but males were less likely
than females to report using a recommended screening
method (OR 0.41, p< 0.005). Finally, there was no difference
in reported rates of routine screening between NPs and
Ob=Gyns, although NPs were less likely to report using a
recommended screening method than Ob=Gyns ( p< 0.001).
Discussion
Improving CRC screening practices is an initiative pro-
moted by several professional societies, including the Ameri-
can College of Obstetricians and Gynecologists (ACOG). This
study is the first to describe current CRC screening practices
and knowledge among Ob=Gyns and NPs in light of the most
recent practice guidelines.2 Our findings suggest that both
provider knowledge and screening practices need improve-
ment, particularly with regard to FOBT use.
Our findings are similar to those of studies of other phy-
sicians. In two national surveys of primary care physicians,
85.1%–98% of participants recommended CRC screening.16,17
In contrast, screening rates among gastroenterologists are
reported to be as high as 98%.15 However, NPs in our study
reported lower screening rates than in previous studies. In
2000, Shaheen et al.18 conducted a survey of NPs and physi-
cian assistants. They reported 69% of primary care NPs re-
ported recommending flexible sigmoidoscopy and 92%
reported performing FOBT.
Current recommendations regarding FOBT testing include
two samples from three consecutive stools that are not rehy-
drated using either a guaiac-based test with dietary restriction
(avoiding red meat) or an immunochemical test without di-
etary restriction.19 For both Ob=Gyns and NPs in our sample,
FOBT (66%) was the diagnostic modality most often used for
screening, but it appears that many are not using it as re-
commended. Almost one third of participants reported rely-
ing on a single stool sample obtained by in-office digital rectal
examination as their screening modality. Similarly, Mu-
sinski20 reported in a retrospective study of gynecology pa-
tients that 43% of CRC screening consisted of a single digital
FOBT. Single-sample digital rectal examination appears to be
a common practice of other primary care providers as well.21
The sensitivity of single digital FOBT is markedly lower
(4.9%) than that of home FOBT kits (23.9%), which assess two
samples from three consecutive stools.21 Further, 66% of prac-
titioners in our study rehydrated stool samples, which is not
recommended in the current guidelines because it decreases
the performance of the assay.19 Finally, 43% of those surveyed
failed to include dietary restrictions when using guaiac-based
FOBT, and a similar proportion reported withholding
NSAIDs, although there are no recommendations to do so.19
The effectiveness of FOBT as a CRC screening tool is de-
termined in part by additional testing, specifically, ordering a
colonoscopy when a positive test occurs. One fifth of our study
participants would repeat the FOBT after a positive result,
which is similar to respondents elsewhere.21 Because impor-
tant lesions may bleed only intermittently, confirmatory FOBT
could miss clinically important lesions.22 Therefore, follow-up
of all positive tests with colonoscopy is indicated.19,22
Despite the fact that FOBT was the most commonly used
modality, providers preferred colonoscopy for themselves.
This discordance could be explained by a number of factors,
including convenience of FOBT, cost, availability or risks of
colonoscopy, and patient compliance. Klabunde et al.23 dem-
onstrated from the 2000 National Health Interview Survey
that 46% of primary care providers cited cost and lack of in-
surance as one of the major barriers to CRC screening. In a
recent survey of primary care providers in Wisconsin, 68.5%
cited cost as the major reason for not recommending colono-
scopy, and 33.2% and 26.1% reported a lack of availability or
risk of perforation, respectively, as barriers to colonoscopy.24
Providers’ expectation of low patient compliance might also
explain the relatively low use of colonoscopy. However,
providers are not particularly good at determining which
features of a diagnostic test are important to patients and
affect their compliance.25
Clearly, opportunities for improving knowledge about
CRC screening exist. For instance, only slightly more than half
(54.6%) of our respondents were able to identify the correct
age to initiate screening in average-risk patients. Performance
in our study was only slightly better than in a 1997 study of
primary care providers (48.5%) but worse than a 1999 survey
of gastroenterologists (71%).15,16 Our findings are disheart-
ening, as CRC screening guidelines for average-risk popula-
tions have been available since 1997. As demonstrated by our
and others’ findings, further education is needed to improve
screening for patients at increased risk for CRC.24,26
We found three provider factors that appeared to be posi-
tively associated with CRC screening. After controlling for
other influencing factors, practitioners in multispecialty
groups were 2.62 times more likely to report routine CRC
screening compared with those in single specialty private
practices. This may be due to enforcement of practice stan-
dards as a result of managed care or group economics. We
also found that providers in practice between 5 and 10 years
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were more likely to report screening than other groups, which
is consistent with other studies suggesting recent graduates
are more likely to screen for CRC than those in practice >10
years.27,28 In previous work, provider gender has also been
shown to affect patient CRC screening adherence. Menees
et al.29 demonstrated that having a female physician was as-
sociated with increased prevalence of CRC screening at the
time of upper endoscopy (EGD) and increased CRC screening
completion in the following 6 months. Other studies have
suggested that patients of female physicians were more likely
to undergo breast and cervical cancer screening than those
with male physicians.30,31 Although female providers in our
study were not more likely to report screening than males,
they were more likely to report using a recommended meth-
od. This result supports previous findings, where women
physicians have been found to be more focused on prevention
than their male counterparts and have more favorable views
and beliefs on prevention.32–34
This study sampled practicing Ob=Gyns and NPs from the
American Medical Association’s membership list. However,
this group may not represent the larger group of practicing
Ob=Gyns or NPs in this country. A more representative
sample of Ob=Gyns would probably be obtained by sampling
members of the ACOG, but their membership lists were not
available. When compared with studies of ACOG members,
our sample tended to be slightly older but had a similar
proportion of female physicians. Further, respondents in our
study and in other studies of ACOG members tend to be in
practice for 10 years.35,36
We also acknowledge several other study limitations. First,
the low response rate (29%) limits the generalizability of our
findings, but it is reassuring that our responses were fairly
consistent with studies of other provider types, some of which
might be expected to be more knowledgeable about CRC
screening than Ob=Gyns. Additionally, as those who respond
to surveys are typically thought to have a particular interest or
knowledge in the study topic, we would expect that our
sample would perform better than nonresponders. Therefore,
our results probably do not underestimate screening practices
or knowledge about CRC screening. Additionally, reporting
bias may be present in these data because we are relying on
self-reported data. Again, we would expect that influence to
result in an overestimate of CRC screening practices. Other
studies have shown that clinicians overestimate their cancer
screening practices.37–39
Conclusions
Our results demonstrate important CRC screening patterns
among Ob=Gyns and NPs. Routine screening for CRC among
Ob=Gyns and NPs is less frequent than screening for other
cancers, such as breast cancer or cervical cancer. Even though
up to 80% of surveyed providers reported performing routine
CRC screening, only 59% routinely screen following re-
commended guidelines, and 53% were able to identify the
correct age to initiate screening. The incorrect use of FOBT
is prevalent especially among Ob=Gyns, as is inadequate
follow-up of positive FOBT results. As many women seek
primary care from Ob=Gyns and NPs, further education of
both healthcare providers and patients may improve com-
pliance with current CRC screening guidelines.
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